| scholarly article | Q13442814 |
| P50 | author | Nancy Raab-Traub | Q90483481 |
| P2093 | author name string | Che-Pei Kung | |
| P2860 | cites work | Erythropoietin-induced serine 727 phosphorylation of STAT3 in erythroid cells is mediated by a MEK-, ERK-, and MSK1-dependent pathway | Q24302357 |
| BCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteins | Q24315909 | ||
| BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription | Q24338268 | ||
| Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappa B homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation | Q24532251 | ||
| The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner | Q24604635 | ||
| STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation | Q24644334 | ||
| Untangling the ErbB signalling network | Q27860884 | ||
| Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma | Q28191706 | ||
| The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers | Q28260566 | ||
| Epidermal growth factor-related peptides and their receptors in human malignancies | Q28293442 | ||
| The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family | Q28307399 | ||
| Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell lines | Q28565703 | ||
| Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling | Q28588278 | ||
| Missing pieces in the NF-kappaB puzzle | Q29547864 | ||
| Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor | Q29616395 | ||
| Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1 | Q29617290 | ||
| STATs in oncogenesis | Q29617571 | ||
| c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor | Q29618661 | ||
| EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas | Q30837949 | ||
| Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression | Q33784729 | ||
| Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression | Q33786551 | ||
| Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors | Q33866046 | ||
| The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance | Q33866655 | ||
| Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins | Q33891012 | ||
| Serine phosphorylation of STATs | Q33941422 | ||
| PROMO: detection of known transcription regulatory elements using species-tailored searches | Q34114282 | ||
| Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice | Q34185116 | ||
| The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines | Q34327176 | ||
| Epstein-Barr virus in the pathogenesis of NPC. | Q35008870 | ||
| Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation | Q35121711 | ||
| The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. | Q35841701 | ||
| The Epstein-Barr virus 3.5-kilobase latent membrane protein 1 mRNA initiates from a TATA-Less promoter within the first terminal repeat | Q35842451 | ||
| Interferon regulatory factor 7 is activated by a viral oncoprotein through RIP-dependent ubiquitination. | Q35856781 | ||
| Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation | Q35875444 | ||
| In vitro activation of Stat3 by epidermal growth factor receptor kinase | Q35924599 | ||
| The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation | Q35997566 | ||
| TRAF2: a double-edged sword? | Q36053266 | ||
| EGF receptor ubiquitination is not necessary for its internalization | Q36089385 | ||
| Unique signaling properties of CTAR1 in LMP1-mediated transformation | Q36098869 | ||
| Reappraisal of BCL3 as a molecular marker of anaplastic large cell lymphoma | Q36420017 | ||
| LMP1 TRAFficking activates growth and survival pathways | Q36882628 | ||
| Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells | Q38322174 | ||
| A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus. | Q39736828 | ||
| Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. | Q39804548 | ||
| Expression of LMP1 in epithelial cells leads to the activation of a select subset of NF-kappa B/Rel family proteins | Q39870850 | ||
| The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB. | Q40061524 | ||
| Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes. | Q40078279 | ||
| Negative regulation of toll-like receptor signaling by NF-kappaB p50 ubiquitination blockade | Q40098564 | ||
| Ras/ERK1/2-mediated STAT3 Ser727 phosphorylation by familial medullary thyroid carcinoma-associated RET mutants induces full activation of STAT3 and is required for c-fos promoter activation, cell mitogenicity, and transformation. | Q40185668 | ||
| Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells | Q40293195 | ||
| Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas | Q40381315 | ||
| Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. | Q40399583 | ||
| Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation | Q40487971 | ||
| Retinoic acid inhibits IL-6-dependent but not constitutive STAT3 activation in Epstein-Barr virus-immortalized B lymphocytes. | Q40535490 | ||
| Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway | Q40623366 | ||
| Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-kappa B2 p100 to p52. | Q40628193 | ||
| The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. | Q41371042 | ||
| GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity | Q42824819 | ||
| Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease | Q43936463 | ||
| IL-2 activation of a PI3K-dependent STAT3 serine phosphorylation pathway in primary human T cells | Q44394226 | ||
| Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis | Q44826931 | ||
| Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation | Q45261333 | ||
| Expression of Epstein-Barr virus (EBV)-encoded latent membrane proteins and STAT3 activation in nasopharyngeal carcinoma | Q45411309 | ||
| Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors | Q45762167 | ||
| Expression of Ki67 antigen, epidermal growth factor receptor and Epstein-Barr virus-encoded latent membrane protein (LMP1) in nasopharyngeal carcinoma | Q45786472 | ||
| The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells. | Q48038156 | ||
| JSI-124 (cucurbitacin I) inhibits Janus kinase-3/signal transducer and activator of transcription-3 signalling, downregulates nucleophosmin-anaplastic lymphoma kinase (ALK), and induces apoptosis in ALK-positive anaplastic large cell lymphoma cells. | Q53602581 | ||
| Stat3 contributes to keloid pathogenesis via promoting collagen production, cell proliferation and migration. | Q53627288 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| membrane protein | Q423042 | ||
| P304 | page(s) | 5486-5493 | |
| P577 | publication date | 2008-03-26 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3. | |
| P478 | volume | 82 |
| Q26741576 | A Central Role for STAT3 in Gammaherpesvirus-Life Cycle and -Diseases |
| Q34151736 | A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer |
| Q39703814 | Activation of the PI3K-Akt pathway by human T cell leukemia virus type 1 (HTLV-1) oncoprotein Tax increases Bcl3 expression, which is associated with enhanced growth of HTLV-1-infected T cells |
| Q37123246 | Autocrine CCL3 and CCL4 induced by the oncoprotein LMP1 promote Epstein-Barr virus-triggered B cell proliferation |
| Q37323455 | Bcl-3, a multifaceted modulator of NF-kappaB-mediated gene transcription |
| Q55213948 | Blockage of store-operated Ca2+ entry antagonizes Epstein-Barr virus-promoted angiogenesis by inhibiting Ca2+ signaling-regulated VEGF production in nasopharyngeal carcinoma. |
| Q38782732 | CD63 Regulates Epstein-Barr Virus LMP1 Exosomal Packaging, Enhancement of Vesicle Production, and Noncanonical NF-κB Signaling |
| Q35677629 | Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3. |
| Q38427527 | Characterization of the latent membrane protein 1 signaling complex of Epstein-Barr virus in the membrane of mammalian cells with bimolecular fluorescence complementation |
| Q40726983 | Clinicopathologic and Immunophenotypic Features of Primary Intestinal Extranodal NK/T-Cell Lymphoma, Nasal Type |
| Q39123741 | Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma. |
| Q33645055 | Cytomegalovirus, Macrophages and Breast Cancer. |
| Q39016871 | Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells |
| Q39756064 | Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status |
| Q37149898 | Epstein-Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant Transformation |
| Q37350214 | Epstein-Barr Virus encoded LMP1 regulates cyclin D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells |
| Q64999568 | Epstein-Barr virus (EBV) activates NKL homeobox gene HLX in DLBCL. |
| Q39595269 | Epstein-Barr virus LMP1 activates EGFR, STAT3, and ERK through effects on PKCdelta |
| Q40046633 | Epstein-Barr virus infection and nasopharyngeal carcinoma |
| Q41981419 | Epstein-Barr virus latent membrane protein 1 modulates distinctive NF- kappaB pathways through C-terminus-activating region 1 to regulate epidermal growth factor receptor expression |
| Q35943724 | Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) and LMP2A function cooperatively to promote carcinoma development in a mouse carcinogenesis model. |
| Q56523156 | HIV vaccine candidate activation of hypoxia and the inflammasome in CD14 monocytes is associated with a decreased risk of SIV acquisition |
| Q34377767 | Human tumor virus utilizes exosomes for intercellular communication. |
| Q52640885 | Induction of chemokine (C-C motif) ligand 5 by Epstein-Barr virus infection enhances tumor angiogenesis in nasopharyngeal carcinoma. |
| Q38927489 | LMP1 promotes expression of insulin-like growth factor 1 (IGF1) to selectively activate IGF1 receptor and drive cell proliferation |
| Q34586289 | Lymphocyte deficiency limits Epstein-Barr virus latent membrane protein 1 induced chronic inflammation and carcinogenic pathology in vivo |
| Q41208796 | MicroRNA Regulation of Glycolytic Metabolism in Glioblastoma. |
| Q92238951 | Modulation of Angiogenic Processes by the Human Gammaherpesviruses, Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus |
| Q35606754 | NF-κB p65 Subunit Is Modulated by Latent Transforming Growth Factor-β Binding Protein 2 (LTBP2) in Nasopharyngeal Carcinoma HONE1 and HK1 Cells |
| Q38596356 | Nasopharyngeal Carcinoma: An Evolving Role for the Epstein-Barr Virus |
| Q37590325 | Regulation of angiogenesis in malignancies associated with Epstein-Barr virus and Kaposi's sarcoma-associated herpes virus |
| Q36239983 | SKF95365 induces apoptosis and cell-cycle arrest by disturbing oncogenic Ca(2+) signaling in nasopharyngeal carcinoma cells |
| Q59354279 | STAT3 is constitutively activated in chronic active Epstein-Barr virus infection and can be a therapeutic target |
| Q90576848 | STAT3 roles in viral infection: antiviral or proviral? |
| Q35924384 | The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim. |
| Q36500037 | The Epstein-Barr virus encoded LMP1 oncoprotein modulates cell adhesion via regulation of activin A/TGFβ and β1 integrin signalling |
| Q35550073 | The translation inhibitor silvestrol exhibits direct anti-tumor activity while preserving innate and adaptive immunity against EBV-driven lymphoproliferative disease |
| Q36241068 | Therapeutic vaccine targeting Epstein-Barr virus latent protein, LMP1, suppresses LMP1-expressing tumor growth and metastasis in vivo |
| Q39787510 | Transcriptional downregulation of p27KIP1 through regulation of E2F function during LMP1-mediated transformation. |
| Q39778922 | Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein-Barr virus lytic cycle induction by HDAC inhibitors |
Search more.